Literature DB >> 3899431

Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus.

T Kumagai, D T Wong, P L Ogra.   

Abstract

The development of natural killer cell and other antibody-independent cellular cytotoxic response to RSV were studied in splenic and pulmonary mononuclear effector cells obtained from groups of 6-week-old cotton rats after subcutaneous (SC) or intranasal (IN) immunization with live virulent or ultra-violet (UV) inactivated respiratory syncytial virus (RSV). No virus-induced cytotoxic activity was observed after SC immunization with live virus or IN inoculation of inactivated non-infectious virus. On the other hand significant cytotoxic activity was observed after IN infection with live RSV. The peak responses appeared on day 4 in the pulmonary cells and on day 7 in the splenic mononuclear cells. These cytotoxic activities declined to baseline levels 10 and 15 days after immunization in pulmonary and splenic cells respectively. In addition, the amount of 51Cr released was significantly reduced when unlabelled 'cold' HEp-2 cells were added to 51Cr-labelled RSV-infected CRF target cells and vice versa in the cytotoxic assay. It is suggested that viral replication at the mucosal site is essential for the induction of local as well as systemic cytotoxic activity following RSV infection. The development of such cellular reactivity may be important in the elimination of RSV following human infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899431      PMCID: PMC1577293     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

2.  Development and characteristics of in-vitro correlates of cellular immunity to rubella virus in the systemic and mucosal sites in guinea pigs.

Authors:  A Morag; K R Beutner; B Morag; P L Ogra
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

3.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

Authors:  J Chin; R L Magoffin; L A Shearer; J H Schieble; E H Lennette
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

Review 5.  Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.

Authors:  M Fishaut; D Tubergen; K McIntosh
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

6.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans.

Authors:  R Scott; A Kaul; M Scott; Y Chiba; P L Ogra
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

8.  Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.

Authors:  F W Bruhn; A S Yeager
Journal:  Am J Dis Child       Date:  1977-02

9.  The pathogenesis of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; A B Jenson; R L Horswood; E Camargo; R M Chanock
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

10.  Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease.

Authors:  R C Welliver; A Kaul; P L Ogra
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

View more
  7 in total

1.  Licensed to kill.

Authors:  G Cambridge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

Review 2.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus.

Authors:  J L Kimpen; P L Ogra
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

4.  Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes.

Authors:  T Matsuoka; Y Okamoto; Z Matsuzaki; S Endo; E Ito; H Tsutsumi; R A Williamson; H Sakurai; D R Burton; I Saito
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

5.  Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.

Authors:  T Kanesaki; B R Murphy; P L Collins; P L Ogra
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.

Authors:  M J Cannon; E J Stott; G Taylor; B A Askonas
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

7.  Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

Authors:  T G Kimman; F Westenbrink; B E Schreuder; P J Straver
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.